Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Another microcap biotech plots major job cuts as industry sharpens its axe amid slowdown
4 years ago
R&D
Rajeev Venkayya, Takeda’s longtime vaccines chief, departs to lead a stealth pandemic-focused biotech
4 years ago
Coded calendar invites, covert emails and deleted documents: Pfizer sues ex-employees for allegedly stealing trade secrets
4 years ago
Pharma
Al Sandrock makes his first post-Biogen move, joining turnaround effort at a troubled gene therapy startup
4 years ago
Pfizer raids Roche executive committee for new drug development chief — and Schwan plucks his replacement from the board
4 years ago
Pharma
Martin Shkreli-associated companies settle anti-competitive lawsuit with insurer for $28M
4 years ago
Troubled Alzheimer's player Cortexyme says goodbye to founding team as independent investor takes chairmanship
4 years ago
DARPA deputy returns home to the UK to lead a new $1B government research agency
4 years ago
Biotech's very bad start to the year continues as microcap gene therapy player Sio ditches CEO, lead partnership
4 years ago
R&D
As sirens blare on biotech public markets, small cell therapy player Gamida plans to axe 10% of staff
4 years ago
Flagship startup brings out the budget ax, chops staff and clinical plans as share price flounders
4 years ago
R&D
Big Pharma R&D legend Paul Stoffels is trading his J&J title for the CEO role at one of the most deeply troubled biotechs in the industry
4 years ago
Novartis marketing vets move on to new commercial roles in biotech
4 years ago
Pharma
CytoDyn fires embattled CEO as its growing chorus of critics gets louder
4 years ago
Zymeworks replaces half its C-suite, aims to lay off 25% of total workforce as new CEO takes over
4 years ago
R&D
Pharma
GSK R&D chief Hal Barron jumps ship to run a $3B biotech startup, Tony Wood tapped to replace him
4 years ago
Martin Shkreli receives lifetime industry ban, forced to return almost $65M in profits after anticompetitive scheme
4 years ago
Pharma
Trailblazing cancer researcher Beatrice Mintz dies at 100 years old
4 years ago
Helsinn, the Braglia family pharma, sees some big changes in leadership as it unveils a new R&D strategy
4 years ago
Q&A: NECI's newest CEO talks passion, disruption and not fearing change
4 years ago
Manufacturing
Daiichi Sankyo shuts down Plexxikon subsidiary to streamline Enhertu, ADC development
4 years ago
R&D
Pharma
Reeling from FDA rejection, BeyondSpring axes 35% of US staffers in hopes of I/O comeback
4 years ago
China
Pharma
Longtime Zymeworks CEO, co-founder Tehrani hits the exit in favor of serial biotech entrepreneur
4 years ago
John Maraganore wanted to become a biotech granddad after leaving Alnylam. With his new role at RTW, it looks like he got his wish
4 years ago
First page
Previous page
50
51
52
53
54
55
56
Next page
Last page